Approvals/CIMA-AEMPS/DAPAGLIFLOZINA/METFORMINA KRKA 5 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

DAPAGLIFLOZINA/METFORMINA KRKA 5 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Krka D.D. Novo Mesto🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 08b29829fff82ca6
Drug Cima Aemps Name: DAPAGLIFLOZINA/METFORMINA KRKA 5 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 90578
Holder Company Name: Krka D.D. Novo Mesto
Marketing Company Name: Krka Farmaceutica S.L.
Authorization Date: 2025-09-25
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 5 mg/850 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Krka D.D. Novo Mesto

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 25, 2025

Approval ID

08b29829fff82ca6

Type

Standard